Dynamin Inhibitors: MiTMAB™ Series Kit (ab120473)
Overview
-
Product name
Dynamin Inhibitors: MiTMAB™ Series Kit -
Specificity
Convenient kit of dynamin inhibitors from the MiTMAB™ chemical series. The inhibitors target dynamin at the lipid binding (PH) domain and inhibit dynamin and endocytosis in enzymatic and cell based assays. They are based on the same chemical scaffold. A negative control compound is also included. Kit contains 1 mg of each of MiTMAB™ (ab120466), OcTMAB™ (ab120467), and Pro-Mystyric Acid (ab120476). -
Product overview
MiTMABTM chemical series collection
Convenient kit of dynamin inhibitors from the MiTMAB™ chemical series. The inhibitors target dynamin at the lipid binding (PH) domain and inhibit dynamin and endocytosis in enzymatic and cell based assays. They are based on the same chemical scaffold. A negative control compound is also included. Kit contains 1 mg of each of MiTMAB™ (ab120466), OcTMAB™ (ab120467), and Pro-Mystyric Acid (ab120476).
Pro-Myristic acid is an in vitro inhibitor of dynamin. Although cell permeable, it is rapidly broken down by cellular esterases to release intracellular myristic acid, which is not a dynamin inhibitor. It can therefore be used as a negative control in cell-based studies.
Target
Description
PH lipid binding site
MiTMAB™:
Cell permeable dynamin I and dynamin II inhibitor
PH lipid binding site
OcTMAB™:
Cell permeable dynamin I and dynamin II inhibitor
PH lipid binding site
Pro-Myristic Acid:
Negative control for MiTMAB™ and OcTMAB™
Convenient kit of dynamin inhibitors from the MiTMAB™ chemical series. The inhibitors target dynamin at the lipid binding (PH) domain and inhibit dynamin and endocytosis in enzymatic and cell based assays. They are based on the same chemical scaffold. A negative control compound is also included. Kit contains 1 mg of each of MiTMAB™ ab120476.
-
Notes
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 6 months.
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one week. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Sold under exclusive licence from Children's Medical Research Institute and Newcastle Innovation Ltd. MiTMAB™ and OcTMAB™ are trademarks of Children's Medical Research Institute and Newcastle Innovation Ltd.
Sold under exclusive licence from Children's Medical Research Institute and Newcastle Innovation Ltd. MiTMAB™ is a trademark of Children's Medical Research Institute and Newcastle Innovation Ltd -
Tested applications
Suitable for: Functional Studiesmore details
Properties
-
Storage instructions
Store at +4°C. Please refer to protocols. -
Components 1 kit ab120466 - MiTMAB™ 1 x 1mg ab120467 - OcTMAB™ 1 x 1mg ab120476 - Pro-Myristic Acid 1 x 1mg -
Research areas
Associated products
-
Related Products
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab120473 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| Functional Studies |
Use at an assay dependent concentration.
|
| Notes |
|---|
|
Functional Studies
Use at an assay dependent concentration. |
Images
-
Functional Studies - OcTMAB™ (ab120467)ab66705 staining PAI1 in HeLa cells treated with OcTMAB™ (ab120467), by ICC/IF. Increase in PAI1 expression correlates with increased concentration of OcTMAB™, as described in literature.
The cells were incubated at 37°C for 24h in media containing different concentrations of ab120467 (OcTMAB™) in DMSO, fixed with 100% methanol for 5 minutes at -20°C and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab66705 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue. -
Functional Studies - MiTMAB™ (ab120466)ab66705 staining PAI1 in HeLa cells treated with MiTMAB™ (ab120466), by ICC/IF. Increase in PAI1 expression correlates with increased concentration of MiTMAB™, as described in literature.
The cells were incubated at 37°C for 24h in media containing different concentrations of ab120466 (MiTMAB™) in DMSO, fixed with 100% methanol for 5 minutes at -20°C and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab66705 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (0)
ab120473 has not yet been referenced specifically in any publications.